Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 10
Submit an article Journal homepage
764
Views
60
CrossRef citations to date
0
Altmetric
Original Article

Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey

Claire F. Snyder Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
,
Susan D. Mathias Health Outcomes Solutions, Winter Park, FL, USA
,
David Cella Evanston Northwestern Healthcare and Northwestern University Medical School, Chicago, IL, USA
,
John J. Isitt Global Health Economics, Amgen, Inc., Thousand Oaks, CA, USACorrespondence[email protected]
,
Albert W. Wu Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Health Policy & Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
&
Joan Young Platelet Disorder Support Association, Potomac, MD, USA
Pages 2767-2776 | Accepted 30 Jul 2008, Published online: 19 Aug 2008

Citations (60)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Wenhui Zhang, Shitong Xie, Rongfeng Fu, Yunfei Chen, Wei Liu, Ting Sun, Mankai Ju, Huiyuan Li, Feng Xue, Lei Zhang, Xiaofan Liu & Renchi Yang. (2023) Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China. Expert Review of Hematology 0:0, pages 1-9.
Read now
Yi Liang, Karen Rascati & Kristin Richards. (2021) Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries. Current Medical Research and Opinion 37:8, pages 1315-1322.
Read now
Patrick Trotter & Quentin A Hill. (2018) Immune thrombocytopenia: improving quality of life and patient outcomes. Patient Related Outcome Measures 9, pages 369-384.
Read now
Hanna Gran Sestøl, Sine Munch Trangbæk, James B Bussel & Henrik Frederiksen. (2018) Health-related quality of life in adult primary immune thrombocytopenia. Expert Review of Hematology 11:12, pages 975-985.
Read now
Abdulgabar Salama. (2017) Emerging drugs for immune thrombocytopenia (ITP). Expert Opinion on Emerging Drugs 22:1, pages 27-38.
Read now
Simon Hallam, Drew Provan & Adrian C Newland. (2013) Immune thrombocytopenia – what are the new treatment options?. Expert Opinion on Biological Therapy 13:8, pages 1173-1185.
Read now
Robert Deuson, Mark Danese, Susan D. Mathias, Marieke Schoonen & Jon Fryzek. (2012) The burden of immune thrombocytopenia in adults: Evaluation of the thrombopoietin receptor agonist romiplostim. Journal of Medical Economics 15:5, pages 956-976.
Read now
Agota Szende, John Brazier, Caroline Schaefer, Robert Deuson, John J. Isitt & Paresh Vyas. (2010) Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura. Current Medical Research and Opinion 26:8, pages 1893-1903.
Read now
Julie Blatt, Brent Weston & Stuart Gold. (2010) FATIGUE AS MARKER OF THROMBOCYTOPENIA IN CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA. Pediatric Hematology and Oncology 27:1, pages 65-67.
Read now
Michael D. Tarantino, Susan D. Mathias, Claire F. Snyder, John J. Isitt, Terry Gernsheimer & Joan Young. (2010) Impact of ITP on physician visits and workplace productivity. Current Medical Research and Opinion 26:2, pages 319-328.
Read now
Susan D. Mathias, Sue K. Gao, Mark Rutstein, Claire F. Snyder, Albert W. Wu & David Cella. (2009) Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences. Current Medical Research and Opinion 25:2, pages 375-383.
Read now

Articles from other publishers (49)

Axel Rüfer & Deirdra R. Terrell. (2023) Burden of immune thrombocytopenia ( ITP ): Special considerations for refractory ITP . British Journal of Haematology 203:1, pages 79-85.
Crossref
Allie J. Tracey, Aaron J. Zynda, Megan C. Loftin, Alyssa M. Pollard-McGrandy, Tamara C. Valovich McLeod & Tracey Covassin. (2023) Concussion History and the Emotional and Behavioral Dyscontrol Domains of Health-Related Quality of Life in College Students. Journal of Athletic Training 58:9, pages 759-766.
Crossref
Jas Bindra, Ishveen Chopra, Kyle Hayes, John Niewoehner, Mary Panaccio & George J. Wan. (2022) Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus. Advances in Therapy 40:1, pages 194-210.
Crossref
Wobke E. M. van Dijk, Marieke C. Punt, Karin P. M. van Galen, Jeanette van Leeuwen, A. Titia Lely & Roger E. G. Schutgens. (2022) Menstrual problems in chronic immune thrombocytopenia: A monthly challenge ‐ a cohort study and review. British Journal of Haematology 198:4, pages 753-764.
Crossref
Alicia Rovó, Nathan Cantoni, Kaveh Samii, Axel Rüfer, Giedre Koenen, Sandra Ivic, Davide Cavanna & Rudolf Benz. (2022) Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium. PLOS ONE 17:4, pages e0267342.
Crossref
Utku Aygüneş & Ayla Uzun Çiçek. (2022) Psychopathological Evaluation In Children with Chronic Idiopathic Trombocytopenic Purpura. Güncel Pediatri 20:1, pages 88-96.
Crossref
Giovanni Caocci, Fabio Efficace, Olga Mulas, Francesco Cottone, Alessia Maxia, Alessandro Costa, Maria Pina Simula, Emilio Usala & Giorgio La Nasa. (2022) Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy. Annals of Hematology 101:4, pages 749-754.
Crossref
Xiaofei Ni, Daqi Li, Chenglu Yuan, Yafei Yu, Haoyi Wang, Lingjun Wang, Tianshu Yu, Ping Qin, Jun Peng, Ming Hou, Yan Shi & Yu Hou. (2022) Single‐dose versus low‐dose rituximab in corticosteroid‐resistant or relapsed ITP : A multicenter, randomized, controlled study . American Journal of Hematology 97:4, pages 440-447.
Crossref
Young Hoon Park, Dae-Young Kim, Seongkoo Kim, Young Bae Choi, Dong-Yeop Shin, Jin Seok Kim, Won Sik Lee, Yeung-Chul Mun, Jun Ho Jang, Jong Wook Lee, Hoon Kook & on behalf of Korean Aplastic Anemia Working Party. (2022) Management of immune thrombocytopenia: 2022 update of Korean experts recommendations. Blood Research 57:1, pages 20-28.
Crossref
. (2021) Mycophenolate Mofetil for Immune Thrombocytopenia. New England Journal of Medicine 385:23, pages 2200-2202.
Crossref
Susan D. Mathias. (2020) I‐WISh : A wish list for immune thrombocytopenia quality of life indicators becomes reality . American Journal of Hematology 96:2, pages 172-173.
Crossref
Nichola Cooper, Alexandra Kruse, Caroline Kruse, Shirley Watson, Mervyn Morgan, Drew Provan, Waleed Ghanima, Donald M. Arnold, Yoshiaki Tomiyama, Cristina Santoro, Marc Michel, Serge Laborde, Barbara Lovrencic, Ming Hou, Tom Bailey, Gavin Taylor‐Stokes, Jens Haenig & James B. Bussel. (2020) Immune thrombocytopenia ( ITP ) World Impact Survey ( I‐WISh ): Impact of ITP on health‐related quality of life . American Journal of Hematology 96:2, pages 199-207.
Crossref
C. Mettler, A. Daguzan, M.-C. Lagouanelle, A. Briantais, P. Ducros, S. Laborde, S. Gouiran, N. Schleinitz, B. Faucher & M. Ebbo. (2021) Attentes en éducation thérapeutique des patients atteints de purpura thrombopénique immunologique et des soignants. La Revue de Médecine Interne 42:1, pages 3-10.
Crossref
Azza A. Tantawy, Nayera H. K. Elsherif, Mahmoud A. Kenny, Khaled A. Aboulfotouh, Ahmed E. Hassan & Marwa E. Kabil. (2020) Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life. Journal of Thrombosis and Thrombolysis 50:2, pages 258-266.
Crossref
Adrian C. Newland, Blanca Sánchez‐González, László Rejtő, Miklos Egyed, Nataliya Romanyuk, Marie Godar, Katrien Verschueren, Domenica Gandini, Peter Ulrichts, Jon Beauchamp, Torsten Dreier, E. Sally Ward, Marc Michel, Howard A. Liebman, Hans Haard, Nicolas Leupin & David J. Kuter. (2019) Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia. American Journal of Hematology 95:2, pages 178-187.
Crossref
晓勇 吴. (2020) Immune Thrombocytopenia-Related Fatigue. Advances in Clinical Medicine 10:09, pages 2162-2168.
Crossref
Ran Yang, Hao Yao, Lin Lin, Jian-min Ji & Qun Shen. (2019) Health-Related Quality of Life and Burden of Fatigue in Chinese Patients with Immune Thrombocytopenia: A Cross-Sectional Study. Indian Journal of Hematology and Blood Transfusion 36:1, pages 104-111.
Crossref
Cindy Neunert, Deirdra R. Terrell, Donald M. ArnoldGeorge BuchananDouglas B. Cines, Nichola CooperAdam CukerJenny M. DespotovicJames N. George, Rachael F. Grace, Thomas KühneDavid J. KuterWendy Lim, Keith R. McCraeBarbara Pruitt, Hayley Shimanek & Sara K. Vesely. (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Advances 3:23, pages 3829-3866.
Crossref
Abderrahim Khelif, Mansoor N. Saleh, Abdulgabar Salama, Maria do Socorro O. Portella, Mei Sheng Duh, Jasmina Ivanova, Kelly Grotzinger, Anuja N. Roy & James B. Bussel. (2019) Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study. American Journal of Hematology 94:2, pages 200-208.
Crossref
Elisa Lucchini, Renato Fanin, Nichola Cooper & Francesco Zaja. (2018) Management of immune thrombocytopenia in elderly patients. European Journal of Internal Medicine 58, pages 70-76.
Crossref
Julie Pell, Rosemary Greenwood, Jenny Ingram, Katherine Wale, Ian Thomas, Rebecca Kandiyali, Andrew Mumford, Andrew Dick, Catherine Bagot, Nichola Cooper, Quentin Hill & Charlotte Ann Bradbury. (2018) Trial protocol: a multicentre randomised trial of first-line treatment pathways for newly diagnosed immune thrombocytopenia: standard steroid treatment versus combined steroid and mycophenolate. The FLIGHT trial. BMJ Open 8:10, pages e024427.
Crossref
Adrian Newland, Eun-Ju Lee, Vickie McDonald & James B Bussel. (2018) Fostamatinib for persistent/chronic adult immune thrombocytopenia. Immunotherapy 10:1, pages 9-25.
Crossref
Robert J. Klaassen & Nancy L. Young. 2018. Antibody Therapy. Antibody Therapy 213 222 .
Richard L Wasserman. (2017) Gammaplex ® 5 and 10% in the treatment of primary immunodeficiency and chronic immune thrombocytopenic purpura . Immunotherapy 9:13, pages 1071-1088.
Crossref
Monika Szkultecka-Dębek, Mariola Drozd & Marta Bem. (2017) The quality of life perception by gender and place of residence during assessment of thrombocytopenia impact on patients’ daily activities using TSIDAV vignette. Polish Journal of Public Health 127:1, pages 24-27.
Crossref
Hirokazu Kashiwagi & Yoshiaki Tomiyama. 2017. Autoimmune Thrombocytopenia　. Autoimmune Thrombocytopenia　 75 84 .
Rachael F. Grace & Cindy Neunert. (2016) Second-line therapies in immune thrombocytopenia. Hematology 2016:1, pages 698-706.
Crossref
Fabio Efficace, Franco Mandelli, Paola Fazi, Cristina Santoro, Gianluca Gaidano, Francesco Cottone, Alessandra Borchiellini, Monica Carpenedo, Maria Pina Simula, Valeria Di Giacomo, Micaela Bergamaschi, Iolanda Donatella Vincelli, Francesco Rodeghiero, Marco Ruggeri, Laura Scaramucci, Alessandro Rambaldi, Nicola Cascavilla, Fabio Forghieri, Annamaria Petrungaro, Paolo Ditonno, Giovanni Caocci, Sonia Cirrincione & Maria Gabriella Mazzucconi. (2016) Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. American Journal of Hematology 91:10, pages 995-1001.
Crossref
Adam Cuker & Cindy E. Neunert. (2016) How I treat refractory immune thrombocytopenia. Blood 128:12, pages 1547-1554.
Crossref
Yutaka Tsukune & Norio Komatsu. (2016) Management of Adult Chronic Immune Thrombocytopenia in Japan: Patient and Hematologist Perspectives from a Multi-center Cross-sectional Questionnaire Survey. Internal Medicine 55:17, pages 2379-2385.
Crossref
Quentin A. Hill & Adrian C. Newland. (2015) Fatigue in immune thrombocytopenia. British Journal of Haematology 170:2, pages 141-149.
Crossref
M. Fernanda López, María Eva Mingot, David Valcárcel, Vicente Vicente García, Allison Perrin & Ignasi Campos Tapias. (2015) Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España. Medicina Clínica 144:9, pages 389-396.
Crossref
M. Fernanda López, María Eva Mingot, David Valcárcel, Vicente Vicente García, Allison Perrin & Ignasi Campos Tapias. (2015) Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain. Medicina Clínica (English Edition) 144:9, pages 389-396.
Crossref
Patricia A. Rhynders, Cynthia A. Sayers, Rodney J. Presley & JoAnn M. Thierry. (2014) Providing Young Women with Credible Health Information about Bleeding Disorders. American Journal of Preventive Medicine 47:5, pages 674-680.
Crossref
Rosarin Sruamsiri, Piyameth Dilokthornsakul, Chayanin Pratoomsoot & Nathorn Chaiyakunapruk. (2014) A Cost-effectiveness Study of Intravenous Immunoglobulin in Childhood Idiopathic Thrombocytopenia Purpura Patients with Life-Threatening Bleeding. PharmacoEconomics 32:8, pages 801-813.
Crossref
L. Chiche, A. Perrin, L. Stern, L. Kutikova, S. Cohen-Nizard & F. Lefrère. (2014) Coût par patient répondeur associé au traitement du purpura thrombopénique immunologique primaire par romiplostim et rituximab chez l’adulte en France. Transfusion Clinique et Biologique 21:2, pages 85-93.
Crossref
John A. D’Orazio, Jessica Neely & Nina Farhoudi. (2013) ITP in Children. Journal of Pediatric Hematology/Oncology 35:1, pages 1-13.
Crossref
Nichola Cooper, Ilaria Terrinoni & Adrian Newland. (2012) The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia. Therapeutic Advances in Hematology 3:5, pages 291-298.
Crossref
S. LAKSHMANAN & A. CUKER. (2012) Contemporary management of primary immune thrombocytopenia in adults. Journal of Thrombosis and Haemostasis 10:10, pages 1988-1998.
Crossref
Deirdra R. Terrell, Laura A. Beebe, Barbara R. Neas, Sara K. Vesely, Jodi B. Segal & James N. George. (2012) Prevalence of primary immune thrombocytopenia in Oklahoma. American Journal of Hematology 87:9, pages 848-852.
Crossref
David J. Kuter, Susan D. Mathias, Mathias Rummel, Romeo Mandanas, Aristoteles A. Giagounidis, Xuena Wang & Robert R. Deuson. (2012) Health‐related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. American Journal of Hematology 87:5, pages 558-561.
Crossref
Julia L. Newton, Jessica A. Reese, Shirley I. Watson, Sara K. Vesely, Paula H. B. Bolton-Maggs, James N. George & Deirdra R. Terrell. (2011) Fatigue in adult patients with primary immune thrombocytopenia. European Journal of Haematology 86:5, pages 420-429.
Crossref
Graham Molineux. (2011) The development of romiplostim for patients with immune thrombocytopenia. Annals of the New York Academy of Sciences 1222:1, pages 55-63.
Crossref
Miguel A. Sanz, Louis Aledort, Susan D. Mathias, Xuena Wang & John J. Isitt. (2011) Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP). Value in Health 14:1, pages 90-96.
Crossref
Daniel U. Rabin, David J. Kuter, Howard A. Liebman & James B. Bussel. (2010) What do healthcare providers ask their patients with immune thrombocytopenia?. American Journal of Hematology 85:8, pages 629-631.
Crossref
Robert J. Klaassen & Nancy L. Young. (2010) Health-related quality of life outcomes for patients with immune thrombocytopenic purpura. Annals of Hematology 89:S1, pages 51-54.
Crossref
Graham Molineux & Adrian Newland. (2010) Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside. British Journal of Haematology.
Crossref
Mohamed Hamidou. (2009) Qualité de vie et Purpura Thrombopénique Immunologique. La Revue de Médecine Interne 30:9, pages H6-H8.
Crossref
Marc Michel. (2009) Immune thrombocytopenic purpura: epidemiology and implications for patients. European Journal of Haematology 82, pages 3-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.